History of aminoquinoline preparations: from cinchona bark to chloroquine and hydroxychloroquinon
DOI:
https://doi.org/10.32687/0869-866X-2020-28-s2-1118-1122Keywords:
chloroquine, hydroxychloroquine, history of antimalarial aminoquinoline medicinesAbstract
The article presents a review of the historical facts related to the discovery and introduction of chloroquine and hydroxychloroquine. The history of studying aminoquinoline preparations is associated with the discovery of the antimalarial action of the bark of the quinine tree, the isolation of quinine from other active substances - alkaloids and the determination of their structure. The structural similarity of quinine and one of the first chemically synthesized dyes - methylene blue-was an important factor at the beginning of the synthesis of molecules with antimalarial activity in the 1930s in Germany. Pamaquin (plasmoquin, plasmoсid), quinacrine (quinacrine, Atebrin, Mepacrine), sontoquine (sontochin), chloroquine, primaquine, hydroxychloroquine, and mefloquine (Lariam) were consistently introduced in medical practice. Many of these medications are no longer widely used. However, chloroquine and hydroxychloroquine have not lost their relevance. The scope of their use has been expanded.References
Flückiger F. A., Hanbury D. Pharmacographia: a history of the principle drugs of vegetable origin, met with in Great Britain and British India. London: MacMillan and Co.; 1874:302-31.
Guerra F. The introduction of Cinchona in the treatment of malaria, parts 1 and 2. J. Trop. Med. Hyg. 1977;80(6):112-8;135-40.
Yalcindag E., Elguero E., Arnathau C., Durand P., Akiana J., Anderson T. J., et al. Multiple independed introductions of Plasmodium falciparum in South America. PNAS. 2012;109(2):511-6. doi: 10.1073/pnas.1119058109
Jarcho S. Quinine's Predecessor: Francesco Torti and the Early History of Cinchona. Baltimore, Maryland: Johns Hopkins University Press; 1993.
Поляков В. Е. Открытия Самуэля Ганемана и история зарождения гомеопатии. Педиатрия. Журнал им. Г. Н. Сперанского. 2015;94(4):99-104.
Sappington J., Stith F. The Theory and Treatment of Fevers. Arrow Rock [Mo.]; 1844. Режим доступа: https://historicmissourians.shsmo.org/historicmissourians/name/s/sappington/
Pelletier P., Caventou J. B. Recherches chimiques sur les quinquinas. Ann. Chim. Phys. 1820;15:289-318.
Chopra R. N. Anti-malarial remedies: natural and synthetic. Calcutta Med. J. 1938;34:183-93.
Dickson D. J.H. On the febrifuge power of the sulphate of quinine. Edinb. Med. Surg. J. 1823;19(77):571-3.
Grove to be sold to bristol-myers. New York Times. Section Business Finance. 1957. P. 35. Режим доступа: https://www.nytimes.com/1957/11/09/archives/grove-to-be-sold-to-bristolmyers-bromoquinine-4way-and-fitch-line.html Режим доступа: https://mycompanies.fandom.com/wiki/Grove_Laboratories https://tennesseeencyclopedia.net/entries/edwin-wiley-grove/
Taylor N. Cinchona in Java: the story of quinine. New York: Greenburg; 1945.
Strecker A. Untersuchungenüber die Constitution des Chinins. Liebigs Ann. 1854;1:155-70.
Schulemann W. Synthetic anti-malarial preparations: a discussion of the various steps which led to the synthesis and discovery of «plasmoquine» and a brief account of its use in tropical medicine. Proc. Roy. Soc. Med. 1932;25:897-905.
Горелова Л. Е. Из истории борьбы с малярией. Русский медицинский журнал. 2009;(7):503-4.
Campbell N. A., Reece J. B., Heyden R. «Biology» Seventh edition. Menlo Park,: Addison Wesley Longman, Inc; 2005.
Hückel W. Vorlesungen über Pharmazeutische Chemie und Arzneimittelsynthese, II. Band, Organische Teil. Stuttgart: Enke; 1962.
Guttmann P., Ehrlich P. Über die Wirkung des Methylenblaubei Malaria. Klin. Wochenschr. 1891;28:953-6.
An epitome of current medical literature. Suppl. BMJ. 1892;47.
Funk E., Potter S. L. Potter's therapeutics, materia medica, and pharmacy. Philadelphia: P. Blakiston's Son & Co.; 1917. 733 p.
Kikuth W. Zur Frage der Malaria Prophylaxe. Hoppe Seylers Z. Physiol. Chem. 1942;274:9-18.
Covell G., Nicol W. D. Clinical, chemotherapeutic, and immunological studies on induced malaria. Br. Med. Bull. 1951;8(1):51-5.
Chernin E. The malaria therapy of neurosyphilis. J. Parasitol. 1984;70(5):611-7.
Burrows J. N., Chibale K., Wells T. N.C. The state of the art in anti-malarial drug discovery and development. Curr. Top. Med. Chem. 2011;11:1226-54.
Chopra R. N. Anti-malarial remedies: natural and synthetic. Calcutta Med. J. 1938;34:183-93.
Кнунянц И. Л., Топчиев К. С., Челинцев Г. В. Строение и синтез новых антималярийных веществ. I. Плазмохин. Известия Академии наук СССР. VII серия. Отделение математических и естественных наук. 1934;(1):153-64.
Elderfield R. C., Gensler W. J., Head J. D., Hageman H. A., Kremer C. B., Wright J. B., et al. Alkylaminoalkyl derivatives of 8-aminoquinoline. J. Am. Chem. Soc. 1946;68(8):1524-9.
Mauss H., Mietzsch F. Atebrin, ein neues Heilmittel gegen Malaria. Klin. Wochenschr. 1933;12(33):1276-8.
Mietzsch F. Entwicklungslinien der Chemotherapie (vom chemischen Standpunktgesehen). Klin. Wochenschr. 1951;29(7-8):125-35.
Greenwood D. Conflicts of interest: the genesis of synthetic antimalarial agents in peace and war. J. Antimicrobial Chem. 1995;36:857-72.
Kodak to Sell Drug Unit for $1.68 Billion. Los Angeles Times. June 24, 1994 (accessed 03.05.2013).
Olmos D. German firm to reclaim Bayer aspirin name: drugs: it will acquire Sterling Winthrop's over-the-counter business and recover the rights it lost after WWI. Los Angeles Times. September 14, 1994 (accessed 03.05.2013).
Кнунянц И. Л., Челинцев Г. В., Беневоленская З. В., Осетрова Е. Д., Курсанова А. И. Строение и синтез новых антималярийных веществ. III. Синтез «Атебрина». Известия Академии наук СССР. VII серия. Отделение математических и естественных наук. 1934;(1):165-76.
«Акрихин» - гордость второй пятилетки. Очерки по истории предприятия. Исторический вестник РХТУ. 2016;48:9-14.
Andersag H. Antimalariamittel aus der Gruppehalogensubstitutierter Chinolinverbindungen. Chem. Ber. 1948;81:499-507.
Wiselogle F. Y. A survey of antimalarial drugs, 1941-1945. Ann Arbor: Edwards, 1946: 987 р.
Slater L. B. War and disease: biomedical research on malaria in the twentieth century. New Brunswick, New Jersey: Rutgers University Press; 2009.
Schlitzer M. Malaria chemotherapeutics. Рart I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development. Chem. Med. Chem. 2007;2:944-86.
Vale N., Moreira R., Gomes P. Primaquine revisited six decades after its discovery. Eur. J. Med. Chem. 2009;44(3):937-53. doi:10.1016/j.ejmech.2008.08.011
Ashley E. A., Recht J., White N. J. Primaquine: the risks and the benefits. Malar. J. 2014;13:418.
Haston J. C., Hwang J., Tan K. R. Guidance for using tafenoquine for prevention and antirelapse therapy for malaria - United States. Morbid. Mortal. Weekly Rep. 2019;68(46):1062-8. doi: 10.15585/mmwr.mm6846a4
Hounkpatin A. B., Kreidenweiss A., Held J. Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data. Infect. Drug Resist. 2019;12:553-70. doi:10.2147/IDR.S151031
Avina-Zubieta J. A., Galindo-Rodriguez G., Newman S., Suarez-Almazor M. E., Russell A. S. Long term effectiveness of antimalarial drugs in rheumatic diseases. Ann. Rheum. Dis. 1998;57:582-7. doi: 10.1136/ard.57.10.582
Quinacrine sterilization: reports on 40,252 cases. Int. J. Gynaecol. Obstet. 2003;83Suppl2:S1-S159.
Published
Issue
Section
License
Authors retain copyright and grant the journal right of the first publication. The article simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
By submitting the article and accompanying files (hereinafter – the “Work”) the author (all the authors of the work, if it is created in co-authorship) agrees that he provides OAO Izdatelstvo Meditsina exclusive and perpetual right to use the work free of charge (exclusive, perpetual and royalty-free license) on the territory of Russia and foreign countries in the following ranges and volume:
- the publication of works on paper and / or electronic format, producing reprints of works, placing it on the Internet, both in the open and paid access, sending works metadata or full text indexing to various databases and repositories;
- reproduction of the work, i.e. the production of one or more copies of a work or part thereof in any material form, including in the form of audio or video recording. Recording on electronic media, including recording in computer memory, is also considered as a reproduction;
- distribution of works through sale or other alienation of its original or copies;
- public display of the work, that is, any demonstration of the original or copy of a work, either directly or on the screen using film, slide, television pictures or other technical means, as well as a demonstration of individual frames of an audiovisual work without concern for their order, either directly or with the help of technical means in a place open for free visits, or in a place where a significant number of individuals do not belong to the normal family, regardless of the perceived in the place of its display or elsewhere at the same time demonstrating product;
- import-export of the work or its parts for any lawful purpose (paid and gratis);
- translation or other processing of the works;
- bringing the work to the public so that anyone can access the work from any place and at any time of their choice;
- accommodation of works or parts thereof in a variety of collections of similar works;
- granting of rights in full or in part to third (physical and legal) persons at both the paid and free of charge.
Author’s items are not provided. The title is available by subscription.